Active Ingredient(s): Abiraterone Acetate
FDA Approved: * May 22, 2018
Pharm Company: * SUN PHARMA GLOBAL
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Yonsa Overview

Abiraterone acetate, sold under the brand name Zytiga among others, is a medication used to treat prostate cancer.[9] Specifically it is used together with a corticosteroid for metastatic castration-resistant prostate cancer (mCRPC) and metastatic high-risk castration-sensitive prostate cancer (mCSPC).[2][3] It should either be used following removal of the testicles or along with a gonadotropin-releasing hormone (GnRH) analog.[2]...

Read more Yonsa Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Abiraterone

Recent Yonsa Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Abiraterone Acetate
  • Tablet: 125mg, 250mg, 500mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Yonsa: (1 result)

Sorted by National Drug Code
  • 47335-401 Yonsa 125 mg Oral Tablet by Sun Pharma Global Fze

Other drugs which contain Abiraterone Acetate or a similar ingredient: (2 results)